Closed-Loop Control and Advisory Mode Evaluation of an Artificial Pancreatic β Cell: Use of Proportional-Integral-Derivative Equivalent Model-Based Controllers

Background: Using currently available technology, it is possible to apply modern control theory to produce a closed-loop artificial β cell. Novel use of established control techniques would improve glycemic control, thereby reducing the complications of diabetes. Two popular controller structures, proportional-integral-derivative (PID) and model predictive control (MPC), are compared first in a theoretical sense and then in two applications. Methods: The Bergman model is transformed for use in a PID equivalent model-based controller. The internal model control (IMC) structure, which makes explicit use of the model, is compared with the PID controller structure in the transfer function domain. An MPC controller is then developed as an optimization problem with restrictions on its tuning parameters and is shown to be equivalent to an IMC controller. The controllers are tuned for equivalent performance and evaluated in a simulation study as a closed-loop controller and in an advisory mode scenario on retrospective clinical data. Results: Theoretical development shows conditions under which PID and MPC controllers produce equivalent output via IMC. The simulation study showed that the single tuning parameter for the equivalent controllers relates directly to the closed-loop speed of response and robustness, an important result considering system uncertainty. The risk metric allowed easy identification of instances of inadequate control. Results of the advisory mode simulation showed that suitable tuning produces consistently appropriate delivery recommendations. Conclusion: The conditions under which PID and MPC are equivalent have been derived. The MPC framework is more suitable given the extensions necessary for a fully closed-loop artificial β cell, such as consideration of controller constraints. Formulation of the control problem in risk space is attractive, as it explicitly addresses the asymmetry of the problem; this is done easily with MPC.

[1]  Nilay Kumar,et al.  Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. , 2007, Diabetes technology & therapeutics.

[2]  A. Sherman,et al.  A mathematical model of metabolic insulin signaling pathways. , 2002, American journal of physiology. Endocrinology and metabolism.

[3]  C. Thompson,et al.  Insulin sensitivity after phototherapy for seasonal affective disorder , 1992, The Lancet.

[4]  T. Harris,et al.  "Internal model control. 4. PID controller design." Comments , 1987 .

[5]  Carlos E. Garcia,et al.  Internal model control. A unifying review and some new results , 1982 .

[6]  Roman Hovorka Management of diabetes using adaptive control , 2005 .

[7]  Carlos E. García,et al.  Fundamental Process Control , 1988 .

[8]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[9]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[10]  B. Bequette A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[11]  Claudio Cobelli,et al.  Physiologic Evaluation of Factors Controlling , 1981 .

[12]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[13]  V. Bolie,et al.  Coefficients of normal blood glucose regulation. , 1961, Journal of applied physiology.

[14]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[15]  J. Richalet,et al.  Model predictive heuristic control: Applications to industrial processes , 1978, Autom..

[16]  Howard Zisser,et al.  Glucose Estimation and Prediction through Meal Responses Using Ambulatory Subject Data for Advisory Mode Model Predictive Control , 2007, Journal of diabetes science and technology.

[17]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[18]  M. Morari,et al.  Internal model control: PID controller design , 1986 .

[19]  D. Cox,et al.  Symmetrization of the Blood Glucose Measurement Scale and Its Applications , 1997, Diabetes Care.

[20]  G M Steil,et al.  Modeling insulin action for development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[21]  Robert S. Parker,et al.  Advanced model predictive control (MPC) for type I diabetic patient blood glucose control , 2000, Proceedings of the 2000 American Control Conference. ACC (IEEE Cat. No.00CH36334).

[22]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[23]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[24]  Thomas F. Edgar,et al.  Process Dynamics and Control , 1989 .

[25]  C. R. Cutler,et al.  Dynamic matrix control¿A computer control algorithm , 1979 .

[26]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[27]  I-Lung Chien,et al.  Consider IMC Tuning to Improve Controller Performance , 1990 .